Patented technologies for your success
Today, enGenes Biotech GmbH fearlessly embraces the opportunities that lie ahead, as we have unwavering faith in the future.
We understand the significance of sustainable biotechnology and merge the forces of nature and scientific advancement to actualize economical and future-ready solutions.
We hold quality in high regard, recognizing it as a virtue, and view sustainability as a valuable asset. We consider innovation as a collaborative endeavor that will redefine the landscape of our biotech industry.
We develop innovative, sustainable solutions to answer our client's most complicated challenges.
Learn more about our technologies
Publications
enGenes-eXpress
enGenes-eXpress technology enables the growth-decoupled production of biomolecules using E. coli, allowing for higher productivity, improved quality and reduced production costs. With its versatility, the technology can be used for the production of various biomolecules, including recombinant proteins, plasmid DNA, RNA, and small molecules, making it a valuable tool in bioprocessing. The phage-derived inhibitor peptide used in the technology is a breakthrough innovation that has the potential to revolutionize the production of biomolecules, particularly in the pharmaceutical and biotech industries.
enGenes-eXtra
The enGenes-eXtra technology enables the extracellular production of recombinant proteins by secretion, utilizing the periplasmic space of E. coli and a leaky outer membrane to release the protein into the extracellular space. This approach allows for simplified purification processes and potentially higher yields of the desired protein. enGenes-X-tra technology is not only a novel and efficient way for extracellular production of recombinant proteins by secretion, but it also offers cost-effectiveness through reduced downstream processing needs, making it an attractive option for clients seeking high-quality protein production.
enGenes-eXpand
The enGenes-eXpand technology for site-specific incorporation of non-canonical amino acids (NCAAs) has vast applications in fields like protein engineering, drug discovery, and biotechnology, by enabling the synthesis of modified proteins with tailored properties, as well as cost-effective incorporation of NCAAs into proteins for bioconjugation through click-chemistry.
enGenes-eXcite
enGenes-eXcite is a cutting-edge technology that enables the continuous manufacturing of biomolecules using E. coli, providing very high productivity at a very small footprint. With its high yield and scalability, enGenes-eXcite represents a promising solution for the cost-effective and sustainable production of biomolecules.
enGenes-eXcess
enGenes-eXcess technology is an efficient and robust platform for the manufacturing of high-quality plasmid DNA. Its upstream and downstream processes have been optimized to enable significant yield improvements and facilitate large-scale production of plasmid DNA for gene therapy and vaccine development. This technology allows for precise and reproducible production of high-quality plasmid DNA in a cost-effective manner.
enGenes-eXchange
The enGenes-eXchange technology offers a sustainable solution for antibiotic resistance marker-free recombinant protein production, using modified plasmids and E. coli strains that allow for antibiotic-free manufacturing of recombinant proteins and plasmid DNA. The technology offers a viable alternative to traditional methods that rely on the use of antibiotics, resulting in safer and more environmentally friendly production.
